Your browser is no longer supported. Please, upgrade your browser.
ONCE Spark Therapeutics, Inc. daily Stock Chart
Spark Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.36 Insider Own7.10% Shs Outstand38.71M Perf Week-0.41%
Market Cap4.18B Forward P/E- EPS next Y-3.94 Insider Trans-42.12% Shs Float35.60M Perf Month-2.30%
Income-86.80M PEG- EPS next Q-1.21 Inst Own92.70% Short Float5.09% Perf Quarter113.52%
Sales69.80M P/S59.93 EPS this Y72.30% Inst Trans-11.58% Short Ratio0.91 Perf Half Y175.87%
Book/sh11.90 P/B9.08 EPS next Y16.70% ROA-11.00% Target Price104.97 Perf Year47.85%
Cash/sh10.82 P/C9.99 EPS next 5Y17.00% ROE-16.70% 52W Range34.53 - 114.20 Perf YTD176.09%
Dividend- P/FCF- EPS past 5Y2.90% ROI-35.40% 52W High-5.38% Beta2.43
Dividend %- Quick Ratio5.60 Sales past 5Y- Gross Margin85.10% 52W Low212.95% ATR1.18
Employees368 Current Ratio5.90 Sales Q/Q32.50% Oper. Margin- RSI (14)40.80 Volatility1.12% 1.09%
OptionableYes Debt/Eq0.11 EPS Q/Q-14.60% Profit Margin- Rel Volume0.15 Prev Close109.05
ShortableYes LT Debt/Eq0.10 EarningsMay 21 Payout- Avg Volume2.00M Price108.06
Recom2.90 SMA20-0.51% SMA50-2.74% SMA20059.11% Volume301,069 Change-0.91%
Feb-25-19Downgrade Cantor Fitzgerald Overweight → Neutral $80 → $114.50
Jan-10-19Reiterated Cantor Fitzgerald Overweight $103 → $80
Nov-16-18Upgrade Credit Suisse Underperform → Neutral
Nov-07-18Upgrade Wedbush Underperform → Neutral $40
Nov-07-18Upgrade Raymond James Outperform → Strong Buy
Nov-07-18Upgrade B. Riley FBR Neutral → Buy $68 → $71
Oct-10-18Initiated Guggenheim Buy
Aug-08-18Reiterated Stifel Buy $76 → $68
Aug-08-18Reiterated Chardan Capital Markets Neutral $60 → $85
Aug-07-18Upgrade Citigroup Neutral → Buy
Aug-07-18Downgrade Credit Suisse Outperform → Underperform
Jul-19-18Downgrade RBC Capital Mkts Outperform → Sector Perform
Jun-28-18Initiated B. Riley FBR, Inc. Neutral $74
May-09-18Reiterated Barclays Overweight $64 → $85
May-01-18Initiated Citigroup Neutral $85
Apr-23-18Downgrade Chardan Capital Markets Buy → Neutral $80 → $85
Feb-21-18Reiterated Stifel Buy $73 → $64
Feb-14-18Downgrade JP Morgan Overweight → Neutral
Feb-13-18Initiated Mizuho Buy $79
Feb-08-18Resumed RBC Capital Mkts Outperform $65
May-20-19 07:23PM  Prem Watsa Buys Buffett's Red Hat, Boosts Micron in 1st Quarter
May-16-19 04:14AM  Adage Capital Managements Latest Portfolio Moves Insider Monkey
May-14-19 09:50AM  $4.8B Roche-Spark deal delayed, once again American City Business Journals
01:28AM  Roche pushes back Spark takeover again as regulatory review drags on Reuters
01:01AM  Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc. GlobeNewswire
May-07-19 10:30AM  Will Spark Therapeutics (ONCE) Report Negative Q1 Earnings? What You Should Know Zacks
May-03-19 05:31PM  Mario Gabelli's Top 7 Buys of the 1st Quarter
May-02-19 11:57AM  Did Hedge Funds Drop The Ball On Spark Therapeutics Inc (ONCE) ? Insider Monkey
Apr-26-19 11:16AM  Roche extends $4.8B Spark tender offer deadline for second time American City Business Journals
08:02AM  The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug Benzinga
02:23AM  Roche faces further delay in $4.3 billion Spark deal amid FTC review Reuters
02:20AM  Roche faces further delay in $4.3 bln Spark deal amid FTC review Reuters
02:02AM  Roche again extends $4.3 blillion offer for Spark amid FTC review Reuters
01:01AM  Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc. GlobeNewswire
Apr-18-19 10:29AM  Roche's (RHHBY) Q1 Sales Strong on Solid Demand for New Drugs Zacks
Apr-17-19 07:30AM  Spark Therapeutics Announces Sponsorship of Believe Limiteds First-Ever Science Fair for the Hemophilia Community at 2019 National Hemophilia Foundations Bleeding Disorders Conference GlobeNewswire
05:03AM  Swiss drugmaker Roche ups outlook as sales growth offsets price hit Reuters
Apr-15-19 03:38PM  Spark Therapeutics (ONCE) Merger Class Action Lawsuit: Halper Sadeh LLP Announces Filing of Shareholder Class Action Lawsuit Against Spark Therapeutics, Inc. Concerning Its Proposed Merger With Roche Holdings, Inc. ONCE GlobeNewswire
08:43AM  Want an insiders way to play IPOs? This fund has had outsize success with its strategy MarketWatch
Apr-12-19 10:02AM  Ophthotech Gets Rights to Gene Therapy for BEST Disease Zacks
Apr-11-19 03:33PM  Biotechnology Market on a Tear: 5 ETFs in Spotlight Zacks
Apr-09-19 02:52PM  COMPLAINTS FILED - ELLI and ONCE: Levi & Korsinsky, LLP Reminds Investors of Complaints Filed Concerning the Sale of these Companies ACCESSWIRE
Apr-08-19 09:45AM  4 Gene Therapy Players Likely to Become Buyout Targets in 2019 Zacks
Apr-05-19 08:00AM  Health Day Checkup of Medical ETFs: 5 Top Picks Zacks
Apr-04-19 11:00PM  Rigrodsky & Long, P.A. Files Class Action Suit Against Spark Therapeutics, Inc. GlobeNewswire
Apr-03-19 03:53PM  Deals of the day-Mergers and acquisitions Reuters
10:29AM  Roche extends deadline for Spark Therapeutics shareholders in $4.8B deal American City Business Journals
10:15AM  Sangamo Rises on Positive Phase I/II Hemophilia Study Data Zacks
09:49AM  Roche Extends Offer Period for Spark Therapeutics Acquisition Zacks
09:43AM  Roche Buys More Time in $4.3B Offer for Spark Therapeutics
08:19AM  The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis Earnings Benzinga
06:18AM  European shares scale eight-month high on trade optimism, strong data Reuters
04:20AM  Roche says $4.3 billion Spark offer still on track for June completion Reuters
03:53AM  European shares climb for fourth day on trade optimism, China data Reuters
01:37AM  Roche extends Spark offer after getting only 29 pct Reuters
01:01AM  Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc. GlobeNewswire
Mar-27-19 12:45PM  6 Gene Therapy M&A Targets On The Radar Benzinga
Mar-22-19 02:13PM  Lifshitz & Miller LLP Announces Investigation of AVEO Pharmaceuticals, Inc., CenturyLink, Inc., Inogen, Inc., Mattel, Inc., Spark Therapeutics, Inc.,, Inc., Syneos Health, Inc., and Weight Watchers, Inc. PR Newswire
Mar-20-19 12:06PM  The 10 months that led to the proposed $4.8B sale of Spark Therapeutics American City Business Journals
Mar-18-19 04:20PM  Spark Unlikely To Get A Better Bid But These Stocks Could Be In Play Investor's Business Daily
Mar-14-19 11:21AM  Life Sciences Pa. reveals awards for its top CEO, top products and deal of the year American City Business Journals
Mar-12-19 11:54AM  SPARK THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout GlobeNewswire
Mar-11-19 10:24PM  SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Spark Therapeutics, Inc. - ONCE PR Newswire
Mar-10-19 10:36AM  10 Stocks For The Gene Therapy Revolution Investopedia
Mar-08-19 10:40AM  Gene Therapy M&A Has Shares Skyrocketing -- Could This Company Be Next? Motley Fool
09:35AM  Roche's (RHHBY) Tecentriq Gets EC Nod for First-Line NSCLC Zacks
08:00AM  Rare Disease Therapies Draw Big Biopharma's Interest ACCESSWIRE
Mar-07-19 11:36AM  Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in cash GlobeNewswire
Mar-06-19 01:19PM  The Roche Merger Will Do Wonders for Spark Stock InvestorPlace
Mar-05-19 04:53PM  Biogen to Acquire Gene-Therapy Company Nightstar for $800M Zacks
01:09PM  Why Spark Therapeutics Stock Soared 137% in February Motley Fool
Mar-04-19 02:50PM  Biotech stocks are tracking for their best quarter ever here's how to play it CNBC
12:27PM  MERGER ALERT LABL and ONCE: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies GlobeNewswire
Mar-01-19 08:38PM  [$$] The Side Effects of Million-Dollar Drugs The Wall Street Journal
09:29AM  Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices Zacks
08:30AM  [$$] The Side Effects of Million-Dollar Drugs The Wall Street Journal
Feb-27-19 04:25PM  Biotech Stock Roundup: ONCE, CMTA Soar on Merger News, Other Pipeline Updates Zacks
09:53AM  The Zacks Analyst Blog Highlights: Spark Therapeutics, Solid Biosciences, REGENXBIO, Editas Medicine and uniQure Zacks
Feb-26-19 05:51PM  MERGER ALERT LABL, CMTA and ONCE: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies GlobeNewswire
02:00PM  Whose wallets will be fattened by the sale of Spark Therapeutics? American City Business Journals
12:54PM  SPARK THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Business Wire
11:15AM  Biotech ETFs Jump on Roche-Spark Deal Zacks
09:30AM  Company News For Feb 26, 2019 Zacks
08:54AM  5 Gene Therapy Stocks to Enrich Your Portfolio Zacks
07:19AM  2 More Gene Therapy Stocks on Big Pharma's Buyout Radar Motley Fool
Feb-25-19 07:51PM  [$$] Why There Is No Sticker Shock in Biotech The Wall Street Journal +120.09%
06:07PM  Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Spark Therapeutics, Inc. (ONCE) on Behalf of Stockholders and Encourages ONCE Investors to Contact the Firm GlobeNewswire
05:48PM  Mario Gabelli's take on today's flurry of M&A activity CNBC Videos
05:08PM  Children's Hospitals $50 Million Bet Turns Into a $456 Million Payday Bloomberg
05:04PM  Stock Market Today: Roche Buys Spark Therapeutics and Investors Digest Berkshire's Annual Letter Motley Fool
04:36PM  Spark and GE rise while Barrick Gold slides Associated Press
04:19PM  3 Things to Know at Market Close: ETF Inflows, Spark Therapeutics, Palo Alto
04:09PM  Roche Is Buying Spark Now These Other Gene Therapy Stocks Are In Play Investor's Business Daily
04:06PM  Dow Closes Modestly Higher After Trump Extends China Tariff Deadline
03:12PM  Sell-Side Picks Top Gene Therapy Takeout Candidates Following Spark Therapeutics Deal Benzinga
02:21PM  Here's Why Gene Therapy Stocks Are Soaring Today Motley Fool
01:17PM  Roche 'steps up' for gene therapy with $4.3 bln Spark bet Reuters
12:53PM  Why Investors Should Cash Out Of This Soaring Biotech Stock
12:03PM  Why Spark Therapeutics Is Skyrocketing 120% Today Motley Fool
11:37AM  Spark Therapeutics Rockets as Roche Pays $4.3 Billion for Gene Therapy Experts
11:29AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Spark Therapeutics, Inc. to Roche is Fair to Shareholders GlobeNewswire
11:17AM  Gene-therapy stocks surge on Roche-Spark deal MarketWatch
11:02AM  Roche Bids $4.8 Billion for Spark and Its Gene Therapy Bloomberg
09:12AM  Spark Therapeutics Stock Doubles, Netflix Gains and More Monday Morning Movers
08:56AM  Pharma M&A Wave: Spark Therapeutics, Clementia Pharma Among The Rare Disease Biotechs Acquired Benzinga
08:33AM  [$$] Why There Is No Sticker Shock in Biotech The Wall Street Journal
08:33AM  Roche Deal for Spark Therapeutics Shows Biotech M&A Spark Hasn't Died
08:31AM  Roche (RHHBY) to Acquire Spark Therapeutics for $4.8 Billion Zacks
08:06AM  Roche bets $4.3 bln on Spark in gene therapy move Reuters Videos
08:05AM  Trade Talks, Spark, Buffett, Kraft Heinz, 'Green Book' - 5 Things You Must Know
07:19AM  Roche 'steps up' for gene therapy with $4.3 bln Spark bet Reuters
06:46AM  Roche to purchase gene therapy firm Spark in $4.3 billion deal CNBC Videos
06:29AM  Stocks Gain, China Surges, as Trump Delays Tariffs Amid Trade Talk Progress
04:02AM  Roche bets $4.3 billion on Spark in gene therapy move Reuters
03:28AM  Ipsen to buy Clementia Pharmaceuticals in deal worth up to $1.3 billion Reuters
03:03AM  [$$] Roche to buy US biotech Spark Therapeutics in $4.8bn deal Financial Times
01:38AM  Roche Has a $5 Billion Chance to Lead on Drug Prices Bloomberg
01:28AM  Roche to Buy Spark for $4.8 Billion
01:15AM  Roche to buy gene therapy specialist Spark in $4.3 bln deal Reuters
01:01AM  Roche enters into definitive merger agreement to acquire Spark Therapeutics GlobeNewswire
Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. Its products include LUXTURNA (voretigene neparvovec) for the treatment of patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy and viable retinal cells. The company's gene therapy product candidates comprise SPK-8011 and SPK-8016 for hemophilia; SPK-7001 for choroideremia; and SPK-9001 for hemophilia B. It is also developing other liver-directed gene therapies, including SPK-3006 for Pompe disease; and neurodegenerative disease product candidates to address Huntington's disease and others, as well as TPP1 deficiency, which is a form of Batten disease. The company's preclinical programs targets inherited retinal diseases, including Stargardt's disease. The company has collaboration agreement with Pfizer, Inc. for the development and commercialization of SPK-FIX product candidates in its gene therapy program for the treatment of hemophilia B. It also has licensing and commercialization agreement with Novartis to develop and commercialize voretigene neparvovec outside the United States. Spark Therapeutics, Inc. was founded in 2013 and is headquartered in Philadelphia, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
La Barge JosephChief Legal OfficerMar 25Option Exercise55.5795,0035,278,87465,596Mar 27 07:20 PM
Faga DanielChief Business OfficerMar 25Option Exercise41.25102,7504,238,29384,032Mar 27 07:18 PM
High Katherine ASee RemarksMar 21Option Exercise38.20188,1247,186,318326,067Mar 25 04:36 PM
La Barge JosephChief Legal OfficerMar 19Option Exercise20.2512,559254,32821,482Mar 21 08:49 PM
Marrazzo Jeffrey DChief Executive OfficerMar 15Option Exercise3.4549,940172,293355,215Mar 19 05:26 PM
Children's Hospital of Philade10% OwnerFeb 27Sale113.002,000,000226,000,0001,954,957Mar 01 04:18 PM
Mehra AnandDirectorJan 04Option Exercise3.4537,203128,35038,703Jan 08 04:30 PM
Marrazzo Jeffrey DChief Executive OfficerDec 28Option Exercise3.456,00020,700299,354Jan 02 05:12 PM
Altschuler StevenDirectorMay 31Option Exercise0.001,500026,500May 31 09:29 PM